Malignant Progression

Malignant Progression is a biological process in neoplastic transformation characterized by the sequential acquisition of genetic and epigenetic alterations that confer increasingly aggressive phenotypic traits, such as enhanced proliferation, invasion, metastasis, and resistance to cell death, distinguishing it from benign neoplasia or non-progressive dysplasia.

7.7K

Publications

469.6K

Citations

44.8K

Authors

5K

Institutions

Publications per year

2017–2026

3K

Authors

44.8K

  1. SH
    Stuart H. Yuspa

    National Cancer Institute, United States

    19 publications · 2.1K citations

    18

    h-index

  2. AF
    Alfredo Fusco

    Institute for Experimental Endocrinology and Oncology, Italy

    23 publications · 1.9K citations

    18

    h-index

  3. EW
    Enhua Wang

    China Medical University, China

    19 publications · 600 citations

    15

    h-index

  4. TJ
    Tao Jiang

    Capital Medical University, China

    14 publications · 1.3K citations

    14

    h-index

  5. AB
    Adam B. Glick

    National Cancer Institute, United States

    12 publications · 864 citations

    12

    h-index

1–5 of 44.8K

Venues

  1. PubMed

    Repository · 857 publications · 55.1K citations

    122

    h-index

  2. Cancer Research

    271 publications · 33.6K citations

    101

    h-index

  3. Proceedings of the National Academy of Sciences

    PNAS · 116 publications · 18.3K citations

    75

    h-index

  4. International Journal of Cancer

    175 publications · 11.5K citations

    65

    h-index

  5. PLoS ONE

    160 publications · 9.7K citations

    57

    h-index

1–5